CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 97 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $593 | -30.8% | 27,152 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $857 | +15.2% | 26,945 | -11.6% | 0.00% | 0.0% |
| Q1 2023 | $744 | -42.7% | 30,487 | -26.0% | 0.00% | -50.0% |
| Q4 2022 | $1,299 | -99.9% | 41,171 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,163,000 | +15.7% | 41,152 | +8.3% | 0.00% | +100.0% |
| Q2 2022 | $1,005,000 | -5.7% | 38,006 | +24.8% | 0.00% | 0.0% |
| Q1 2022 | $1,066,000 | +15.2% | 30,454 | +6.8% | 0.00% | 0.0% |
| Q4 2021 | $925,000 | +23.2% | 28,526 | +12.0% | 0.00% | 0.0% |
| Q3 2021 | $751,000 | -3.0% | 25,467 | -15.7% | 0.00% | 0.0% |
| Q2 2021 | $774,000 | – | 30,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |